Atlas Trials

Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection

Clinical trial NCT05307835 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05307835
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Resectable Esophageal Cancer
Start date
2021-12-02
Primary completion
2026-06-30
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.